The Gross Law Firm has issued a notice to shareholders of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) regarding an ongoing class action lawsuit. Investors who purchased shares of VTGN have until March 16, 2026, to apply to be lead plaintiff in the case.
The firm encourages eligible shareholders to review the details and consider their options before the deadline. This legal action pertains to claims involving Vistagen Therapeutics and its securities.
**Why this matters**
The lead plaintiff in a class action lawsuit plays a significant role in representing the interests of all affected investors. Meeting the deadline is crucial for shareholders who wish to participate in the litigation process and potentially seek compensation.
Source: NewsData